Early research (Phase 1)Study completedNCT05604209
What this trial is testing
Safety and Immunogenicity of HIV-1 Vaccines C62-M4 or C1C62-M3M4 in Persons With HIV-1 Suppressed on ART
Who this might be right for
HIV VaccineHIV-1-infection
University of North Carolina, Chapel Hill 18